Trial intelligence / Profile preview

Cryoballoon Ablation vs Medical Therapy in Persistent Atrial Fibrillation

NCT02389218Phase 4Completed

Sponsor
Ghent University Hospital
Start
Mar 2015
Primary completion
May 2020
Countries
1
01

Overview

Phase 4, randomised, open-label trial in Atrial fibrillation (AFib), sponsored by Ghent University Hospital. Primary endpoint: Sinus rhythm at 1 year. Started Mar 2015; status: completed.

02

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT02389218.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02389218.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call